Loading
Sotera Health Co Stock: price and insider trades · United States
Insider Decl.
164
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3B
29 ops. · all time
Who traded when
BuySaleGTCR Investment XI LLC5 sales
Michael B. Petras Jr.5 sales
Pincus & Co. Warburg5 sales
Michael P. Rutz2 sales
Analyst consensus: bullish or bearish?
Analysts rate Sotera Health Co Buy (bullish), based on 9 analysts. Average price target: US$22.61.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 12,941 of 26,248 companies
51.8
score / 100
Value42
Quality62
FCF yld2.9%
Earn yld1.5%
EV/EBITDA16.8x
ROE28%
Gross mgn55%
Net mgn6.7%
Debt/EBITDA5.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$17.93
Analyst consensus
9 analystsBuy
US$17.00Target US$22.61(+26%)US$25.00
Income statement
RevenueUS$1.2B
Gross profitUS$645.5M55% margin
EBITDAUS$439.9M38% margin
Net incomeUS$77.9M13.4% margin
Valuation
PER (trailing)31.5x
PER (forward)16.7x
P/Book7.7x
Beta1.86
Balance sheet & cash
Market capUS$5.1B
Total debtUS$2.3B
Free Cash FlowUS$149.2M
Debt / Equity341%
Profitability & ownership
ROE27.8%
ROA8.6%
% insiders2.4%
% institutions100.4%
Last declaration on 19 August 2026
Declarations164 total
294,515 shares@ US$18.50110.10% mcap18.3% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-356962:0
850,000 shares@ US$18.50110.30% mcap52.9% of flowCommon StockSEC:0001193125-26-356962:1
1,144,515 shares@ US$18.89100.0% of flowCommon StockSEC144:0001968582-26-000852
150,000 shares@ US$18.8350.053% mcap29.2% of flowCommon Stock, $0.01 par value per shareSEC:0001193125-26-344757:0
150,000 shares@ US$18.910.054% mcap29.3% of flowCommonSEC144:0001949846-26-000475
11,316 shares@ US$17.980.0038% mcap32.3% of flowCommon Stock, $0.01 par value per shareSEC:0001193125-26-340288:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242237:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242188:0
14,970 shares0Common Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-242231:0
12,735,301 shares@ US$15.1683.29% mcap17.6% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-227029:0
19,102,952 shares@ US$15.1684.93% mcap17.6% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-010899:0
7,941 shares@ US$14.3432.3% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-140422:0
15,000,000 shares@ US$15.2714.1% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001999371-26-005534:0
10,000,000 shares@ US$15.2714.1% of flowCommon Stock, $0.01 par value per share ("Common Stock")SEC:0001193125-26-100568:0
14,573 sharesCommon StockSEC:0001193125-26-092194:2
45,223 shares0Common StockSEC:0001193125-26-092194:4
16,816 sharesCommon StockSEC:0001193125-26-092210:1
89,686 sharesCommon StockSEC:0001193125-26-092231:2
240,248 shares0Common StockSEC:0001193125-26-092231:5
17,937 sharesCommon StockSEC:0001193125-26-092207:1
59,355 shares0Common StockSEC:0001193125-26-092207:4
4,495 shares@ US$15.910.6% of flowCommon StockSEC:0001193125-26-092194:1
17,497 shares@ US$15.912.4% of flowCommon StockSEC:0001193125-26-092194:3
23,619 shares@ US$15.9151.2% of flowCommon StockSEC:0001193125-26-092210:2
40,302 shares@ US$15.910.6% of flowCommon StockSEC:0001193125-26-092231:1
25 of 164 declarations
About Sotera Health Co
At Sotera Health Co, a US healthcare company valued at USD 5.12 billion, no purchase appears among 164 insider filings published from November 24, 2020 to August 19, 2026. The 29 sales total EUR 2,900,617,552, with a median of EUR 103,704,979.
Pincus & Co. Warburg (Director) signs the three largest: EUR 297,045,316 on March 22, 2021, EUR 247,313,368 on May 13, 2026 and EUR 244,041,034 on November 10, 2025. GTCR Investment XI LLC (Director) has 8 filings, all sales, as does Pincus & Co. Warburg. On top come 122 grants, 4 option exercises and 9 filings of another kind.
Read moreShow less
Among executives, Michael B. Petras Jr. (Executive Chairman) is the most frequent filer with 33 filings, 7 of them sales, ahead of Michael P. Rutz (President of Sterigenics) with 24 and Jonathan M. Lyons (Sr. Vice President, CFO) with 13, none a sale. Annual volume rises to 34 in 2025 and 33 in 2026. Over the last twelve months: 40 filings, of which 14 sales and no purchase.
